Skip to main content

Want a detailed portfolio tracker?

Coya Therapeutics (COYA) P/E (2023 - 2026)

Coya Therapeutics (COYA) P/E from Jan 3, 2023 to Jul 21, 2026. The TTM Coya Therapeutics (COYA) P/E is -4.25. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Coya Therapeutics (COYA)

YearP/EChange
2026-4.25-12.05%
2025-4.83-17.85%
2024-5.88-9.39%
2023-6.49N/A

Comparison Coya Therapeutics (COYA) P/E with competitors

Coya Therapeutics (COYA) P/E is -4.25.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.10%
ENLVEnlivex Ltd0.07-101.76%
FGENFibroGen Inc0.24-105.65%
CHRSCoherus Biosciences Inc0.85-119.97%
FBIOFortress Biotech Inc0.95-122.34%
ORMPOramed Pharmaceuticals Inc1.50-135.37%
AGENAgenus Inc3.01-170.83%
INVAInnoviva Inc3.15-174.23%
VXRTVaxart Inc3.55-183.54%
CRMDCorMedix Inc3.63-185.39%
CVACCureVac N.V.4.45-204.63%
GLPGGalapagos NV4.86-214.35%
SRPTSarepta Therapeutics Inc4.88-214.90%
ABEOAbeona Therapeutics Inc5.39-226.79%
ABUSArbutus Biopharma Corp5.60-231.69%
ZVRAZevra Therapeutics Inc5.89-238.55%
SPROSpero Therapeutics Inc6.23-246.58%
CGENCompugen Ltd6.31-248.60%
RIGLRigel Pharmaceuticals6.87-261.73%
SLXNSilexion Therapeutics Corp7.30-271.71%
OMEROmeros Corporation9.26-317.90%
AUPHAurinia Pharmaceuticals Inc9.58-325.58%
PLXProtalix BioTherapeutics Inc10.89-356.32%
ACADAcadia Pharmaceuticals Inc11.73-376.03%
TBPHTheravance Biopharma Inc12.26-388.59%
ADMAAdma Biologics Inc12.42-392.26%
HRMYHarmony Biosciences Holdings Inc13.82-425.26%
SABSSAB Biotherapeutics Inc14.14-432.69%
NAGENiagen Bioscience Inc14.82-448.74%
INCYIncyte Corp15.82-472.38%
REGNRegeneron Pharmaceuticals Inc15.86-473.18%
PBYIPuma Biotechnology Inc17.32-507.52%
CPRXCatalyst Pharmaceuticals Inc17.44-510.43%
EXELExelixis Inc17.54-512.75%
TGTXTG Therapeutics Inc18.97-546.36%
MDXGMimedx Group Inc20.55-583.70%
XOMAXOMA Royalty Corp22.87-638.37%
ARGXArgen X SE24.30-671.87%
CTMXCytomX Therapeutics Inc24.82-684.18%
XOMAOXOMA Royalty Corp25.34-696.50%
HALOHalozyme Therapeutics Inc25.62-703.07%
XOMAPXOMA Royalty Corp25.67-704.16%
VRTXVertex Pharmaceuticals Inc27.99-758.87%
RPRXRoyalty Pharma plc - Class A28.69-775.17%
SLNOSoleno Therapeutics Inc29.02-782.89%
ASNDAscendis Pharma A/S30.09-808.08%
LGNDLigand Pharmaceuticals Inc - Class B37.91-992.28%
APLSApellis Pharmaceuticals Inc39.02-1018.38%
BMRNBiomarin Pharmaceutical Inc42.21-1093.48%
KRYSKrystal Biotech Inc45.34-1167.18%
ONCBeiGene Ltd69.54-1736.67%
PHARPharming Group N.V.75.03-1865.76%
TECHBio-Techne Corp101.96-2499.64%
VCELVericel Corp109.92-2687.05%
ALNYAlnylam Pharmaceuticals Inc117.96-2876.37%
GMABGenmab140.29-3401.81%
TLXTelix Pharmaceuticals Ltd162.15-3916.35%